Vatera Healthcare Partners LLC insider trades: Melinta Therapeutics (MLNT) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Vatera Healthcare Partners LLC reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 29, 2018 | MLNT | ↑ Buy | 7,878,500 | $5.00 | $39.4M | Indirect | May 31, 2018 (2d) |
| May 29, 2018 | MLNT | ↑ Buy | 7,500,000 | $5.00 | $37.5M | Direct | May 31, 2018 (2d) |
| Jan 5, 2018 | MLNT | ↑ Buy | 2,000,000 | $13.50 | $27.0M | Indirect | Jan 9, 2018 (4d) |
| Jan 5, 2018 | MLNT | ↑ Buy | 1,777,778 | $13.50 | $24.0M | Direct | Jan 9, 2018 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Vatera Healthcare Partners LLC's insider trades
Vatera Healthcare Partners LLC is a director at Melinta Therapeutics (MLNT). Since Jan 5, 2018, it has reported 4 open-market purchases worth $127.9M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MLNT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.